Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CELC stock hub

Celcuity Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CELCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.3B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
CELC
In the news

Latest news · CELC

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-163.8
P25 -105.6P50 -46.5P75 -3.1
ROIC-33.8
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CELC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001603454
Company name
Celcuity Inc.
Country
United States
Country code
US
Cusip
15102K100
Employees
155
Employees Change
68%
Employees Change Percent
78.16
Enterprise value
$6.2B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2017-09-20
Isin
US15102K1007
Last refreshed
2026-05-10
Market cap
$6.3B
Market cap category
Mid-Cap
Price
$131
Price currency
USD
Sector
Healthcare
Sic
8071
Symbol
CELC
Website
https://www.celcuity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-2.79%
FCF yield
-2.42%
P/B ratio
62.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-177M
Net Income Growth Years
0%
Profit Per Employee
$-1.1M
ROA
-30.24
Roa5y
-27.99
ROCE
-40.76
ROE
-163.8
Roe5y
-82.29
ROIC
-33.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
1,189.68%
Cagr3y
138.29%
Cagr5y
37.02%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
$466.6M
Cash
$441.5M
Current Assets
$465.7M
Current Liabilities
$44.2M
Debt
$321.9M
Debt Equity
$3.2
Equity
$100.6M
Interest Coverage
-10.04
Liabilities
$366M
Long Term Assets
$899,000
Long Term Liabilities
$321.9M
Net Cash
$119.6M
Net Cash By Market Cap
$1.89
Net Cash Growth
-12.8%
Net Debt Equity
$-1.19
Tangible Book Value
$100.5M
Tangible Book Value Per Share
$2.08
WACC
4.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
10.55
Net Working Capital
$-19.9M
Quick ratio
10
Working Capital
$421.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-18.53%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
1,187.43%
200-day SMA
87.93
3Y total return
1,253.93%
50-day SMA
117.9
50-day SMA vs 200-day SMA
50over200
5Y total return
382.9%
All Time High
151
All Time High Change
-13.22%
All Time High Date
2026-05-04
All Time Low
4.03
All Time Low Change
3,152.11%
All Time Low Date
2020-04-16
ATR
8.39
Beta
0.09
Beta1y
-1.42
Beta2y
0.36
Ch YTD
31.4
High
133.4
High52
151
High52 Date
2026-05-04
High52ch
-13.22%
Low
129.2
Low52
9.51
Low52 Date
2025-05-15
Low52ch
1,278.13%
Ma50ch
11.2%
Premarket Change Percent
-0.12
Premarket Price
$131
Premarket Volume
2,250
Price vs 200-day SMA
49.05%
RSI
55.53
RSI Monthly
92.43
RSI Weekly
77.49
Sharpe ratio
1.91x
Sortino ratio
10.03
Total Return
-18.53%
Tr YTD
31.4
Tr1m
13.41%
Tr1w
4.31%
Tr3m
22.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
9
Analyst Count Top
4
Analyst Price Target Top
$153
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.93
Operating Income
$-172.2M
Price target
$132
Price Target Change
$0.38
Price Target Change Top
$16.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
29,655,741%
Float Percent
61.35%
Net Borrowing
231,250,000
Shares Insiders
9.3%
Shares Institutions
67.15%
Shares Out
48,336,675
Shares Qo Q
10.4%
Shares Yo Y
18.53%
Short Float
29.68%
Short Ratio
11.67
Short Shares
18.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-174.9M
Average Volume
1,058,794.45x
Bv Per Share
2.08
CAPEX
$-249,000
Ch1m
13.41
Ch1w
4.31
Ch1y
1,187.4
Ch3m
22.77
Ch3y
1,253.9
Ch5y
382.9
Ch6m
75.87
Change
0.27%
Change From Open
0.27
Close
130.7
Days Gap
0
Depreciation Amortization
167,000
Dollar Volume
104,811,958.5
Earnings Date
2026-05-14
Earnings Time
amc
EBIT
$-172.2M
EBITDA
$-172M
EPS
$-3.79
F Score
2
FCF
$-153.5M
FCF EV Yield
-2.47x
FCF Per Share
$-3.18
Financing CF
360,552,000
Fiscal Year End
December
Founded
2,011
Investing CF
-64,084,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-25
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-26
Ma150
101
Ma150ch
29.79%
Ma20
125.8
Ma20ch
4.21%
Net CF
143,188,000
Next Earnings Date
2026-05-14
Open
130.7
Optionable
Yes
Position In Range
43.88
Post Close
131.1
Postmarket Change Percent
-0.43
Postmarket Price
$131
Ppne
550,000
Pre Close
130.7
Price Date
2026-05-08
Ptbv Ratio
63.06
Relative Volume
0.76x
Share Based Comp
21,383,000
Tr6m
75.87%
Us State
Minnesota
Volume
799,725
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CELC pay a dividend?

Capital-return profile for this ticker.

Performance

CELC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+1187.4%
S&P 500 1Y: n/a
3Y total return
+1253.9%
S&P 500 3Y: n/a
5Y total return
+382.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CELC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+67.1%
Float: +61.4% of shares outstanding
Insider ownership
+9.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+29.7%
11.7 days to cover
Y/Y dilution
+18.5%
Negative means the company is buying back shares.
Technical

CELC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.5
Neutral momentum band
Price vs 200-day MA
+49.0%
50/200-day relationship not available
Beta (5Y)
0.09
Less volatile than the market
Sharpe ratio
1.91
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CELC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CELC stock rating?

Celcuity Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CELC analysis?

The full report lives at /stocks/CELC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CELC?

The latest report frames CELC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CELC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.